0001127602-23-030485.txt : 20231227
0001127602-23-030485.hdr.sgml : 20231227
20231227161138
ACCESSION NUMBER: 0001127602-23-030485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231227
FILED AS OF DATE: 20231227
DATE AS OF CHANGE: 20231227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIERENGA WENDALL
CENTRAL INDEX KEY: 0001235945
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 231518060
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
STREET 2: C/O NEUROCRINE BIOSCIENCES
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: WIERENGA WENDALL D
DATE OF NAME CHANGE: 20030527
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-12-27
0001061983
CYTOKINETICS INC
CYTK
0001235945
WIERENGA WENDALL
350 OYSTER POINT BLVD
SOUTH SAN FRANCISCO
CA
94080
1
1
Common Stock
2023-12-27
4
M
0
5000
4.44
A
23653
D
Common Stock
2023-12-27
4
S
0
5000
73.60
D
18653
D
Common Stock
2023-12-27
4
M
0
5000
4.44
A
23653
D
Common Stock
2023-12-27
4
S
0
5000
73.60
D
18653
D
Non-Qualified Stock Option (Right to Buy)
4.44
2023-12-27
4
M
0
5000
0
D
2014-06-21
2024-05-21
Common Stock
5000
5000
D
Non-Qualified Stock Option (Right to Buy)
4.44
2023-12-27
4
M
0
5000
0
D
2014-06-21
2024-05-21
Common Stock
5000
0
D
Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023.
This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015.
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
2023-12-27